Please use this identifier to cite or link to this item:
http://publications.jrc.ec.europa.eu/repository/handle/JRC94665| Title: | Ac-225-DOTATOC – an empiric dose finding for alpha particle emitter based radionuclide therapy of neuroendocrine tumors |
| Authors: | KRATOCHWIL Clemens; BRUCHERTSEIFER Frank; GIESEL Frederik; APOSTOLIDIS Christos; HABERKORN Uwe; MORGENSTERN Alfred |
| Citation: | JOURNAL OF NUCLEAR MEDICINE vol. 56 no. S3 p. 1232 |
| Publisher: | SOC NUCLEAR MEDICINE INC |
| Publication Year: | 2015 |
| JRC N°: | JRC94665 |
| ISSN: | 0161-5505 |
| URI: | http://jnm.snmjournals.org/content/56/supplement_3.toc http://publications.jrc.ec.europa.eu/repository/handle/JRC94665 |
| Type: | Articles in periodicals and books |
| Abstract: | There are no established dosimetry tools to predict toxicity of “targeted alpha-therapy” (TAT), yet. We conducted an empiric dose escalation to find the maximum tolerable dose (MTD) of single cycle and fractionation concepts for Ac-225-DOTATOC radionuclide therapy. |
| JRC Directorate: | Nuclear Safety and Security |
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.